Presentation on Optimal Dosing Strategy for Subcutaneous Infliximab in IBD

During the Digestive Disease Days, Luc Derijks delivered a presentation on the optimal dosing strategy for subcutaneous infliximab in both adults and children with inflammatory bowel disease (IBD). The presentation was based on a simulation study, providing valuable insights into treatment approaches for this patient population.

Geef uw mening over de website, of vertel ons hoe wij onze website kunnen verbeteren.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.